6533b7d7fe1ef96bd1267b41
RESEARCH PRODUCT
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study.
Frank RoeschChandrasekhar BalSanjana BallalEuy Sung MoonMadhav Prasad YadavBharadwaj Srinivas ManguMadhavi TripathiRanjit Kumar SahooSamta KumariShipra AgarwalAvinash Tupallisubject
AdultMaleEndocrinology Diabetes and MetabolismSalvage treatmentIndiaPilot ProjectsEndocrinologyFibroblast activation protein alphaRefractoryPositron Emission Tomography Computed TomographyMedicineHumansProspective StudiesThyroid NeoplasmsPrecision MedicineThyroid cancerProtein Kinase InhibitorsAgedbusiness.industryPhenylurea CompoundsMiddle AgedSorafenibmedicine.diseaseCancer researchQuinolinesFemalebusinessdescription
Background: This exploratory study was to assess clinical and safety data with a novel fibroblast activation protein inhibitor-based targeted theranostics as a salvage treatment option in radioiodi...
year | journal | country | edition | language |
---|---|---|---|---|
2021-12-31 | Thyroid : official journal of the American Thyroid Association |